A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease
Clinical trial NCT03478956 · TERMINATED
Trial details
- NCT number
- NCT03478956
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-27
- Primary completion
- 2019-12-02
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.